Gut and saliva microbiota changes after taking Bacillus coagulans probiotics
Official title: Analysis of the Gut Microbiota Composition After Consumption of Probiotic Bacteria
Run by Lund University · NCT07046897 · Data updated 2026-11-12
We will test whether taking a Bacillus coagulans probiotic for 14 days changes the bacteria in stool and saliva of healthy adults aged 18–65.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Lund University Academic / other |
| Locations | 1 site (Lund) |
| Status | Recruiting |
| Started | November 12, 2024 |
| Main results expected | June 30, 2025 |
| Study ends | June 30, 2025 |
| Registry record updated | July 2, 2025 |
| Trial ID | NCT07046897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults aged 18–65 who are not on antibiotics, do not have gastrointestinal or autoimmune diseases or immune-suppressing conditions, and agree to avoid other probiotic or fermented foods during the study.
✕Probably not a fit
People with diagnosed GI or autoimmune diseases, significant immune deficiency, recent antibiotic use, or those already using other probiotic products are unlikely to receive benefit from this healthy-volunteer study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Healthy adults aged 18–65 will take a freeze-dried Bacillus coagulans probiotic daily for 14 days and collect saliva and fecal samples before and after the intervention. Samples will be frozen immediately and analyzed at Lund University using Illumina MiSeq sequencing and the QIIME2 pipeline to measure species composition, diversity, and relative abundance. People with gastrointestinal disease, autoimmune conditions, recent antibiotic use, or who consume other probiotic products or fermented foods are excluded. The study asks whether the probiotic produces changes in microbiota composition that would be considered beneficial.
Why it matters
Potential benefit: If successful, the results could support using Bacillus coagulans to beneficially shift saliva and gut microbiota in healthy people and guide future research for clinical applications.
How similar studies have gone: Previous probiotic research has produced mixed results—some trials report microbiota changes while others do not—and evidence specific to Bacillus coagulans in healthy adults remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • You must be 18-65 years of age. Exclusion Criteria: * Participants must not be diagnosed with gastrointestinal diseases, autoimmune diseases or have diseases or medications that cause immune deficiency such as MS, type 1 diabetes, cancer or HIV. * Participants must not have taken antibiotics in the month before or during the study. * Participants must not consume other probiotic products or fermented foods during the study.
Where it's running
-
Department of Process and Life Science Engineering, Lund University
Lund, Sweden Recruiting
Study contacts
- Principal investigator: Åsa Håkansson, Associate Professor — Lund University, LTH
- Study coordinator: Åsa Håkansson, Associate Professor
- Email: asa.hakansson@ple.lth.se
- Phone: +46 46 2228326
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Cesarean Bundle: better communication to help decide about cesareans
This trial tests a three-part Cesarean Bundle to see if it improves how patients and clinicians talk about planned cesareans and trust in care.
-
Noninvasive optical-ultrasound imaging to look inside tissues
A safe, light-based imaging method called ultrasound optical tomography (UOT) is tested in healthy volunteers to see how deep it can image and what tissue looks like, with long-term aim of helping breast cancer detection.
-
Plant-based beverage effects on the gut microbiome in healthy adults
This study tests how drinking different plant-based beverages for two weeks affects the gut microbiome in healthy adults.
-
Self‑manual lymph drainage for head and neck lymphedema
This trial will test whether different intensities of self‑applied manual lymph drainage help people with head and neck lymphedema after radiotherapy for oropharyngeal cancer.
-
Digital self- and remote monitoring for chronic pain in primary care to improve quality of life
This study will test whether adults with chronic pain can use the Paindrainer app and CARE portal to better monitor their symptoms and activity and improve quality of life while managed in primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.